| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Kinase Kinases | 8 | 2013 | 190 | 0.980 |
Why?
|
| Ubiquitination | 8 | 2013 | 575 | 0.940 |
Why?
|
| NF-kappa B | 9 | 2012 | 1549 | 0.720 |
Why?
|
| Social Media | 1 | 2022 | 203 | 0.640 |
Why?
|
| Lysine | 6 | 2013 | 422 | 0.600 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 2 | 2014 | 21 | 0.570 |
Why?
|
| Polyubiquitin | 2 | 2013 | 23 | 0.480 |
Why?
|
| Ubiquitin Thiolesterase | 4 | 2014 | 216 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2014 | 1538 | 0.400 |
Why?
|
| Gene Amplification | 1 | 2014 | 731 | 0.380 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2014 | 301 | 0.370 |
Why?
|
| Doxorubicin | 4 | 2014 | 3005 | 0.370 |
Why?
|
| I-kappa B Kinase | 5 | 2010 | 250 | 0.360 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 726 | 0.340 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 1283 | 0.270 |
Why?
|
| Breast Neoplasms | 9 | 2015 | 15694 | 0.260 |
Why?
|
| Ubiquitin-Specific Proteases | 3 | 2014 | 73 | 0.250 |
Why?
|
| Neuroblastoma | 3 | 2014 | 686 | 0.230 |
Why?
|
| Signal Transduction | 8 | 2014 | 11965 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 2 | 2010 | 246 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 300 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8873 | 0.160 |
Why?
|
| HeLa Cells | 5 | 2012 | 1643 | 0.160 |
Why?
|
| Apoptosis | 5 | 2014 | 7591 | 0.150 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2014 | 716 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2014 | 1489 | 0.140 |
Why?
|
| Fibroblasts | 5 | 2014 | 1682 | 0.130 |
Why?
|
| Etoposide | 2 | 2014 | 870 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2014 | 1764 | 0.120 |
Why?
|
| Zearalenone | 1 | 2013 | 6 | 0.120 |
Why?
|
| Cell Line, Tumor | 6 | 2014 | 14551 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 334 | 0.120 |
Why?
|
| Receptor, ErbB-2 | 2 | 2015 | 2518 | 0.120 |
Why?
|
| Mice | 13 | 2014 | 34495 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2010 | 37 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 249 | 0.120 |
Why?
|
| Papilloma | 1 | 2013 | 74 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2014 | 93 | 0.110 |
Why?
|
| Cell Line | 5 | 2012 | 5114 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 185 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2014 | 234 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1077 | 0.110 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 205 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.110 |
Why?
|
| Mammaglobin A | 1 | 2012 | 14 | 0.110 |
Why?
|
| Fluorouracil | 2 | 2015 | 1944 | 0.110 |
Why?
|
| Thiophenes | 1 | 2013 | 148 | 0.110 |
Why?
|
| Clonal Evolution | 1 | 2014 | 253 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 210 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 255 | 0.100 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 222 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 2232 | 0.100 |
Why?
|
| Protein Binding | 3 | 2013 | 3438 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 3552 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 550 | 0.100 |
Why?
|
| Ultrasonography, Mammary | 1 | 2013 | 380 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2014 | 4804 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 214 | 0.100 |
Why?
|
| Genome | 1 | 2014 | 672 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2010 | 88 | 0.090 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 372 | 0.090 |
Why?
|
| Thiolester Hydrolases | 1 | 2010 | 34 | 0.090 |
Why?
|
| Animals | 13 | 2014 | 59536 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2012 | 854 | 0.090 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2015 | 509 | 0.090 |
Why?
|
| Humans | 23 | 2022 | 261506 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2009 | 184 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2012 | 747 | 0.080 |
Why?
|
| Lysophospholipids | 1 | 2009 | 147 | 0.080 |
Why?
|
| Binding Sites | 1 | 2013 | 2171 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 1216 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1070 | 0.080 |
Why?
|
| Cell Survival | 1 | 2014 | 3045 | 0.070 |
Why?
|
| Computational Biology | 1 | 2014 | 1271 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2015 | 780 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 1960 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 1392 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2014 | 7226 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2014 | 1818 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 1879 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2086 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1130 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2012 | 1664 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2022 | 0.060 |
Why?
|
| Vesiculovirus | 2 | 2014 | 17 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2015 | 3251 | 0.060 |
Why?
|
| Interferon Regulatory Factor-3 | 2 | 2014 | 32 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Female | 13 | 2015 | 141928 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 4757 | 0.050 |
Why?
|
| Interleukin-6 | 3 | 2010 | 1038 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 7222 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 611 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 644 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2015 | 3890 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 741 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2014 | 4307 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2014 | 5178 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 4938 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3821 | 0.030 |
Why?
|
| Epirubicin | 1 | 2015 | 157 | 0.030 |
Why?
|
| Middle Aged | 7 | 2015 | 86204 | 0.030 |
Why?
|
| Rhabdoviridae Infections | 1 | 2014 | 5 | 0.030 |
Why?
|
| DEAD Box Protein 58 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6207 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2014 | 167 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2014 | 256 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 14289 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2009 | 1152 | 0.030 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2013 | 23 | 0.030 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2013 | 40 | 0.030 |
Why?
|
| Aged | 6 | 2015 | 70117 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 29902 | 0.030 |
Why?
|
| Trisomy | 1 | 2014 | 231 | 0.030 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2014 | 113 | 0.030 |
Why?
|
| Mutation | 4 | 2014 | 15179 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 323 | 0.030 |
Why?
|
| Adult | 6 | 2015 | 77950 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 214 | 0.030 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2013 | 134 | 0.030 |
Why?
|
| Thoracic Wall | 1 | 2015 | 183 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 15862 | 0.030 |
Why?
|
| Karyotyping | 1 | 2014 | 1022 | 0.030 |
Why?
|
| Protein Phosphatase 2C | 1 | 2012 | 75 | 0.030 |
Why?
|
| Trastuzumab | 1 | 2015 | 696 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2012 | 102 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2011 | 79 | 0.030 |
Why?
|
| Chromogranin A | 1 | 2011 | 65 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 551 | 0.020 |
Why?
|
| Heterografts | 1 | 2013 | 733 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 244 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2015 | 37905 | 0.020 |
Why?
|
| Image-Guided Biopsy | 1 | 2013 | 327 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2014 | 470 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 7548 | 0.020 |
Why?
|
| Yin-Yang | 1 | 2010 | 4 | 0.020 |
Why?
|
| Oncogenes | 1 | 2013 | 673 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1313 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 507 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2009 | 39 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2014 | 785 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 370 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 1869 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 591 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2009 | 35 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 677 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 2489 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 2231 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 886 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 1904 | 0.020 |
Why?
|
| Point Mutation | 1 | 2012 | 769 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 2944 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 634 | 0.020 |
Why?
|
| Mastectomy | 1 | 2015 | 1534 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 744 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1987 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1408 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2015 | 1996 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 3001 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 1489 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2013 | 1026 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 396 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 2483 | 0.020 |
Why?
|
| Prognosis | 2 | 2015 | 21713 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 2216 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 2086 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 488 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.020 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1215 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5710 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 2403 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3981 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8865 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 6942 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10001 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 4975 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7573 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 4821 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 4053 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 12926 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 14889 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 5270 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 5542 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17523 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10035 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 10331 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 32848 | 0.010 |
Why?
|
| Male | 1 | 2014 | 123000 | 0.000 |
Why?
|